HLA-B*39

06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression

Jennifer Schloss, Riyasat Ali, Jeremy J. Racine, Harold D. Chapman, David V. Serreze, Teresa P. DiLorenzo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Type 1 diabetes (T1D) is characterized by T cell–mediated destruction of the insulin-producing b cells of the pancreatic islets. Among the loci associated with T1D risk, those most predisposing are found in the MHC region. HLA-B*39:06 is the most predisposing class I MHC allele and is associated with an early age of onset. To establish an NOD mouse model for the study of HLA-B*39:06, we expressed it in the absence of murine class I MHC. HLA-B*39:06 was able to mediate the development of CD8 T cells, support lymphocytic infiltration of the islets, and confer T1D susceptibility. Because reduced thymic insulin expression is associated with impaired immunological tolerance to insulin and increased T1D risk in patients, we incorporated this in our model as well, finding that HLA-B*39:06–transgenic NOD mice with reduced thymic insulin expression have an earlier age of disease onset and a higher overall prevalence as compared with littermates with typical thymic insulin expression. This was despite virtually indistinguishable blood insulin levels, T cell subset percentages, and TCR Vb family usage, confirming that reduced thymic insulin expression does not impact T cell development on a global scale. Rather, it will facilitate the thymic escape of insulin-reactive HLA-B*39:06–restricted T cells, which participate in b cell destruction. We also found that in mice expressing either HLA-B*39:06 or HLA-A*02:01 in the absence of murine class I MHC, HLA transgene identity alters TCR Vb usage by CD8 T cells, demonstrating that some TCR Vb families have a preference for particular class I MHC alleles.

Original languageEnglish (US)
Pages (from-to)3353-3363
Number of pages11
JournalJournal of Immunology
Volume200
Issue number10
DOIs
StatePublished - May 15 2018

Fingerprint

HLA-B Antigens
Type 1 Diabetes Mellitus
Insulin
T-Lymphocytes
Inbred NOD Mouse
Age of Onset
Alleles
T-Lymphocyte Subsets
Transgenes
Islets of Langerhans

ASJC Scopus subject areas

  • Immunology

Cite this

HLA-B*39 : 06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. / Schloss, Jennifer; Ali, Riyasat; Racine, Jeremy J.; Chapman, Harold D.; Serreze, David V.; DiLorenzo, Teresa P.

In: Journal of Immunology, Vol. 200, No. 10, 15.05.2018, p. 3353-3363.

Research output: Contribution to journalArticle

Schloss, Jennifer ; Ali, Riyasat ; Racine, Jeremy J. ; Chapman, Harold D. ; Serreze, David V. ; DiLorenzo, Teresa P. / HLA-B*39 : 06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. In: Journal of Immunology. 2018 ; Vol. 200, No. 10. pp. 3353-3363.
@article{892d2f93fa8e4ecb9bd091f36534de46,
title = "HLA-B*39: 06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression",
abstract = "Type 1 diabetes (T1D) is characterized by T cell–mediated destruction of the insulin-producing b cells of the pancreatic islets. Among the loci associated with T1D risk, those most predisposing are found in the MHC region. HLA-B*39:06 is the most predisposing class I MHC allele and is associated with an early age of onset. To establish an NOD mouse model for the study of HLA-B*39:06, we expressed it in the absence of murine class I MHC. HLA-B*39:06 was able to mediate the development of CD8 T cells, support lymphocytic infiltration of the islets, and confer T1D susceptibility. Because reduced thymic insulin expression is associated with impaired immunological tolerance to insulin and increased T1D risk in patients, we incorporated this in our model as well, finding that HLA-B*39:06–transgenic NOD mice with reduced thymic insulin expression have an earlier age of disease onset and a higher overall prevalence as compared with littermates with typical thymic insulin expression. This was despite virtually indistinguishable blood insulin levels, T cell subset percentages, and TCR Vb family usage, confirming that reduced thymic insulin expression does not impact T cell development on a global scale. Rather, it will facilitate the thymic escape of insulin-reactive HLA-B*39:06–restricted T cells, which participate in b cell destruction. We also found that in mice expressing either HLA-B*39:06 or HLA-A*02:01 in the absence of murine class I MHC, HLA transgene identity alters TCR Vb usage by CD8 T cells, demonstrating that some TCR Vb families have a preference for particular class I MHC alleles.",
author = "Jennifer Schloss and Riyasat Ali and Racine, {Jeremy J.} and Chapman, {Harold D.} and Serreze, {David V.} and DiLorenzo, {Teresa P.}",
year = "2018",
month = "5",
day = "15",
doi = "10.4049/jimmunol.1701652",
language = "English (US)",
volume = "200",
pages = "3353--3363",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - HLA-B*39

T2 - 06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression

AU - Schloss, Jennifer

AU - Ali, Riyasat

AU - Racine, Jeremy J.

AU - Chapman, Harold D.

AU - Serreze, David V.

AU - DiLorenzo, Teresa P.

PY - 2018/5/15

Y1 - 2018/5/15

N2 - Type 1 diabetes (T1D) is characterized by T cell–mediated destruction of the insulin-producing b cells of the pancreatic islets. Among the loci associated with T1D risk, those most predisposing are found in the MHC region. HLA-B*39:06 is the most predisposing class I MHC allele and is associated with an early age of onset. To establish an NOD mouse model for the study of HLA-B*39:06, we expressed it in the absence of murine class I MHC. HLA-B*39:06 was able to mediate the development of CD8 T cells, support lymphocytic infiltration of the islets, and confer T1D susceptibility. Because reduced thymic insulin expression is associated with impaired immunological tolerance to insulin and increased T1D risk in patients, we incorporated this in our model as well, finding that HLA-B*39:06–transgenic NOD mice with reduced thymic insulin expression have an earlier age of disease onset and a higher overall prevalence as compared with littermates with typical thymic insulin expression. This was despite virtually indistinguishable blood insulin levels, T cell subset percentages, and TCR Vb family usage, confirming that reduced thymic insulin expression does not impact T cell development on a global scale. Rather, it will facilitate the thymic escape of insulin-reactive HLA-B*39:06–restricted T cells, which participate in b cell destruction. We also found that in mice expressing either HLA-B*39:06 or HLA-A*02:01 in the absence of murine class I MHC, HLA transgene identity alters TCR Vb usage by CD8 T cells, demonstrating that some TCR Vb families have a preference for particular class I MHC alleles.

AB - Type 1 diabetes (T1D) is characterized by T cell–mediated destruction of the insulin-producing b cells of the pancreatic islets. Among the loci associated with T1D risk, those most predisposing are found in the MHC region. HLA-B*39:06 is the most predisposing class I MHC allele and is associated with an early age of onset. To establish an NOD mouse model for the study of HLA-B*39:06, we expressed it in the absence of murine class I MHC. HLA-B*39:06 was able to mediate the development of CD8 T cells, support lymphocytic infiltration of the islets, and confer T1D susceptibility. Because reduced thymic insulin expression is associated with impaired immunological tolerance to insulin and increased T1D risk in patients, we incorporated this in our model as well, finding that HLA-B*39:06–transgenic NOD mice with reduced thymic insulin expression have an earlier age of disease onset and a higher overall prevalence as compared with littermates with typical thymic insulin expression. This was despite virtually indistinguishable blood insulin levels, T cell subset percentages, and TCR Vb family usage, confirming that reduced thymic insulin expression does not impact T cell development on a global scale. Rather, it will facilitate the thymic escape of insulin-reactive HLA-B*39:06–restricted T cells, which participate in b cell destruction. We also found that in mice expressing either HLA-B*39:06 or HLA-A*02:01 in the absence of murine class I MHC, HLA transgene identity alters TCR Vb usage by CD8 T cells, demonstrating that some TCR Vb families have a preference for particular class I MHC alleles.

UR - http://www.scopus.com/inward/record.url?scp=85047100636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047100636&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1701652

DO - 10.4049/jimmunol.1701652

M3 - Article

VL - 200

SP - 3353

EP - 3363

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -